Skip to content

Effect of subanesthetic dose of esketamine on postoperative sleep disorders after breast cancer surgery

Effect of subanesthetic dose of esketamine on postoperative sleep disorders after breast cancer surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086905
Enrollment
Unknown
Registered
2024-07-15
Start date
2024-03-13
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative sleep disorders

Interventions

Esketamine group:Esketamine was given by intravenous infusion.
control group:The same amount of normal saline was given by intravenous infusion.

Sponsors

Department of Anesthesiology, Wuxi Second People 's Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.Age 18 years old or above 2.ASA : I-III grade 3.Patients undergoing breast cancer surgery

Exclusion criteria

Exclusion criteria: 1.Patients refused to participate in the study ; 2.BMI > 30 ; 3.preoperative Pittsburgh sleep quality index ( PSQI ) > 7 points ; 4.Recent history of drug abuse ; 5.Contraindications or allergies to esketamine ; 6.Cognitive dysfunction or inability to communicate ;

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative sleep disorders;

Secondary

MeasureTime frame
sleep quality;15 Quality of recovery scores;Hospital Anxiety and Depression Scale;NRS score at rest and during exercise;

Countries

China

Contacts

Public ContactMinmin Zhu

Wuxi Second People 's Hospital Affiliated to Nanjing Medical University

mmzhummzhu@163.com+86 139 2129 2032

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026